• LAST PRICE
    2.2600
  • TODAY'S CHANGE (%)
    Trending Down-0.0400 (-1.7391%)
  • Bid / Lots
    2.2500/ 4
  • Ask / Lots
    2.2600/ 1
  • Open / Previous Close
    2.3000 / 2.3000
  • Day Range
    Low 2.1400
    High 2.3800
  • 52 Week Range
    Low 0.3040
    High 3.1790
  • Volume
    3,004,315
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 2.3
TimeVolumeSGMO
09:32 ET894612.335
09:33 ET333102.33
09:35 ET684222.305
09:37 ET196472.31
09:39 ET187362.294
09:42 ET585922.2619
09:44 ET646332.2664
09:46 ET249752.24
09:48 ET355612.27
09:50 ET95252.2799
09:51 ET141792.285
09:53 ET202352.2818
09:55 ET58752.3
09:57 ET188362.282
10:00 ET51002.285
10:02 ET423252.27
10:04 ET103532.256
10:06 ET404212.25
10:08 ET687212.24
10:09 ET152492.24
10:11 ET52962.245
10:13 ET158052.255
10:15 ET104402.2408
10:18 ET323732.21
10:20 ET281862.21
10:22 ET454252.199
10:24 ET351392.19
10:26 ET462062.2
10:27 ET139852.18
10:29 ET425502.185
10:31 ET234782.1949
10:33 ET229462.19
10:36 ET152822.19
10:38 ET260302.185
10:40 ET95722.185
10:42 ET249932.2
10:44 ET781012.185
10:45 ET347982.175
10:47 ET1394572.15
10:49 ET624932.15
10:51 ET501162.14
10:54 ET214602.17
10:56 ET63982.17
10:58 ET268022.19
11:00 ET242642.18
11:02 ET49502.175
11:03 ET120742.1805
11:05 ET166492.2
11:07 ET79952.205
11:09 ET21002.205
11:12 ET226042.19
11:14 ET302332.175
11:16 ET45232.175
11:18 ET166612.1639
11:20 ET228072.165
11:21 ET194362.165
11:23 ET24302.165
11:25 ET93222.1888
11:27 ET73072.19
11:30 ET87372.185
11:32 ET49582.185
11:34 ET189262.195
11:36 ET97352.195
11:38 ET108482.1998
11:39 ET132342.18
11:41 ET330382.1798
11:43 ET766642.16
11:45 ET83722.16
11:48 ET176082.19
11:50 ET25972.1899
11:52 ET25312.185
11:54 ET70822.18
11:56 ET33282.185
11:57 ET28662.18
11:59 ET43942.175
12:01 ET117352.19
12:03 ET24692.1892
12:06 ET271202.2
12:08 ET39582.195
12:10 ET62082.19
12:12 ET73252.19
12:14 ET10582.195
12:15 ET46972.19
12:17 ET24912.18
12:19 ET26052.18
12:21 ET871272.21
12:24 ET288242.2
12:26 ET275132.205
12:28 ET29682.2
12:30 ET149652.205
12:32 ET594462.21
12:33 ET93982.2087
12:35 ET17472.205
12:37 ET261112.205
12:39 ET16292.205
12:42 ET402742.23
12:44 ET212352.23
12:46 ET222402.245
12:48 ET150002.25
12:50 ET173532.25
12:51 ET909652.255
12:53 ET137552.255
12:55 ET358902.24
12:57 ET488472.26
01:00 ET1731292.26
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSGMO
Sangamo Therapeutics Inc
479.9M
-3.2x
---
United StatesARCT
Arcturus Therapeutics Holdings Inc
474.3M
-7.9x
---
United StatesAKBA
Akebia Therapeutics Inc
449.5M
-9.3x
---
United StatesVNDA
Vanda Pharmaceuticals Inc
302.6M
-18.2x
-37.98%
United StatesKMDA
Kamada Ltd
334.0M
19.0x
-22.48%
United StatesSTRO
Sutro Biopharma Inc
221.8M
-1.6x
---
As of 2024-11-29

Company Information

Sangamo Therapeutics, Inc. is a genomic medicines company that is developing medicines for neurological diseases. The Company's neurology preclinical development is focused on two areas: development of epigenetic regulation therapies to treat serious neurological diseases, and development of novel engineered adeno-associated virus (AAV) capsids to deliver its therapies to the intended neurological targets. The Company's zinc finger epigenetic regulators are ideally suited to potentially address neurological disorders and its capsid discovery platform is expanding delivery beyond intrathecal delivery capsids, including in the central nervous system. Its clinical-stage product candidates are Isaralgagene civaparvovec, also known as ST-920, its wholly-owned gene therapy product candidate for the treatment of Fabry disease, and TX200, its wholly-owned CAR-Treg cell therapy product candidate for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation.

Contact Information

Headquarters
501 Canal Blvd.RICHMOND, CA, United States 94084
Phone
510-970-6000
Fax
302-655-5049

Executives

Independent Chairman of the Board
H. Stewart Parker
President, Chief Executive Officer
Alexander Macrae
Principal Financial Officer, Principal Accounting Officer, Vice President - Finance
Prathyusha Duraibabu
Senior Vice President, General Counsel, Corporate Secretary
Scott Willoughby
Senior Vice President, Chief Development Officer
Nathalie Dubois- Stringfellow

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$479.9M
Revenue (TTM)
$52.3M
Shares Outstanding
208.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.15
EPS
$-0.71
Book Value
$0.47
P/E Ratio
-3.2x
Price/Sales (TTM)
9.2
Price/Cash Flow (TTM)
---
Operating Margin
-267.81%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.